Several developing countries now have well-developed
biotechnology programmes; they are approaching the
leading edge of biotechnology applications and have
significant research capacity, according to a new FAO
assessment on the status of research and application of
crop biotechnologies in developing countries.
Based on a review of
the information in the FAO
database on
Biotechnology in Developing Countries (FAO-BioDeC),
which covers both genetically modified (GM) crops and
non-GM biotechnologies, the assessment suggests that
developing countries will soon have new GM crops
available such as virus-resistant papaya, sweet potato
and cassava as well as rice tolerant to abiotic stresses
(salinity and drought).
Focus on food
security
Most of the GMOs
commercialized so far in developing countries have been
acquired from developed countries and focus on a limited
number of traits (mainly herbicide tolerance and insect
pest resistance) and crops (commodities such as cotton,
soybean and maize).
However, the FAO
assessment reveals that several developing countries
have been conducting research on a wider range of crops,
such as banana, cassava, cowpea, plantain, rice and
sorghum, and on traits relevant for food security, such
as abiotic stress tolerance and quality.
Argentina, Brazil,
China, Cuba, Egypt, India, Mexico and South Africa have
taken the lead. A second group of countries has
medium-scale agricultural biotechnology programmes,
usually in a few key areas. Other developing nations
have relatively limited research capacity, according to
the FAO report.
"We hope that
research activities in developing countries will
increasingly focus on issues important for food
security," said Andrea Sonnino, from FAO's Research and
Technology Development Service.
Noticeable gaps
There are, however,
some noticeable gaps in research. For example, no
research is reported in the field of nematode resistance
despite the considerable losses caused by these plant
parasites. Another fundamental but neglected research
problem concerns post-harvest losses.
The study also notes
that biosafety capacity building is needed to enable
many countries in Africa, Eastern Europe, Latin America
and the Near East to fully benefit from GMO technology.
Regarding non-GM
biotechnologies, many are being used on a commercial
scale but only a few studies have been carried out to
assess their socio-economic impacts. The report
highlights that this is an area needing urgent attention
as it is likely to help guide research and technology
policies and investments towards wider and efficient
utilization of all biotechnologies.
FAO-BioDeC
Launched in 2003 as
an on-line searchable database, FAO-BioDeC currently has
about 2 000 entries from 71 developing countries,
including countries with economies in transition.
It is regularly
updated and has recently been expanded to include
extensive data from the forestry sector and some initial
data on livestock.
The assessment
presents a first analysis of the information contained
in the database as of 31 August 2004.